Close

Dendreon (DNDN) Updates Outlook, But Concerns with Provenge Remain; Roth Reiterates 'Sell"

January 16, 2014 9:13 AM EST Send to a Friend
Roth Capital maintained it Sell rating and $2.60 price target on Dendreon Corp. (Nasdaq: DNDN) following the company's recently issued ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login